Sign Out
Ezetimibe is rated as category C.
Use is contraindicated in pregnant women who require combination of ezetimibe and HMG-CoA reductase inhibitor.
The drug should not be used in nursing women unless the potential benefits justify the possible risks to the infant.
Continue with Google